Zeltia cancer drug is rejected
The European Medicines Evaluation Agency rejected an application to approve Yondelis, a controversial cancer treatment developed by Zeltia, a Spanish biotechnology company. Zeltia was last night
The European Medicines Evaluation Agency rejected an application to approve Yondelis, a controversial cancer treatment developed by Zeltia, a Spanish biotechnology company. Zeltia was last night